LP Data

Private Equity · Venture Capital · Global

Clarus Lifesciences Iii, LP

Clarus LifesciencesReported by 2 LPsLatest mark Dec 31, 20237 observations
No LP has reported performance for this fund yet.

Who reports it

Limited partners disclosing this fund. Expand a row for earlier reports.

Limited partnerCommittedNAVNet IRRTVPIDPIAs ofSource
Richard King Mellon Foundation3 reports—$39,811———2023-12-31Source ↗
Robert Wood Johnson Foundation4 reports—$5.6M———2022-12-31Source ↗